Fundz

Fundz Deep Dive

Everything you need to win KORRO BIO, INC. — in one platform.

Who to reach, what to say, and why now on KORRO BIO, INC. — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.

Get the full Deep Dive on KORRO BIO, INC. — free.

One free Deep Dive, emailed to you. No spam; unsubscribe anytime.

Ready now? Choose your plan · Request a demo · Sign in

Engage writes the reply
Grounded in signals no one else has — tuned to their persona.
Signals no one else has
UCC liens, benefit plans, 13F holdings, permits, exec moves — fused.
Verified contact + click-to-call
The decision-maker’s email and mobile — dial in-browser.

Korro Bio Collaborates with Novo Nordisk to Develop Two Therapeutic Candidates

Sep 16, 2024•over 1 year ago

Contract Type

partnership

Cambridge

Description

Korro Bio, Inc. has announced a partnership with Novo Nordisk to advance the discovery and development of new genetic medicines, with the initial target to treat cardiometabolic diseases. The collaboration aims to leverage Korro’s proprietary OPERATM platform to enable oligonucleotide-directed RNA edits into two undisclosed targets, with a total deal value of up to $530 million in upfront, development, and commercial milestone payments, in addition to tiered royalties and R&D funding.

Company Information

Company

KORRO BIO, INC.

Location

400 TECHNOLOGY SQUARE, 10TH FLOOR

Cambridge, Maryland, United States

Predictive Intelligence
Strategic

ML-powered predictions for KORRO BIO, INC.'s next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.